Kathy Rowlen

Dr. Kathy Rowlen is an analytical chemist and biotechnology entrepreneur with extensive experience developing advanced measurement technologies for complex biological systems. She spent 17 years as a Professor of Analytical Chemistry at the University of Colorado, where her research encompassed flow cytometry instrumentation and advanced spectroscopic methods. In 2003, she co-founded InDevR and served as CEO from 2006 through its acquisition by SSI Diagnostica Group in 2026. Dr. Rowlen now serves as Science Advisor, leading InDevR’s efforts to transform raw materials testing for cell and gene therapy.